CVC Explores $2B Sale of Arthea
Private equity firm CVC Capital Partners is exploring a two billion dollar sale for personal care platform Arthea. The company owns popular brands including Dr Teals and Cantu. Discussions regarding the potential transaction remain at an early stage.
Xurve View
Insights:
Xurve View

Private equity firm CVC Capital Partners plc is exploring a $2 billion sale of Arthea, the personal care platform behind Dr. Teal's, according to people familiar with the matter. The potential divestment follows CVC's acquisition of the company, formerly known as PDC Brands, for $1.43 billion in 2017. The personal care sector has seen a surge in M&A activity, with several multibillion-dollar deals completed over the past year.





